Literature DB >> 1357965

X-linked nephrogenic diabetes insipidus: from the ship Hopewell to RFLP studies.

D G Bichet1, G N Hendy, M Lonergan, M F Arthus, S Ligier, Z Pausova, R Kluge, H Zingg, P Saenger, E Oppenheimer.   

Abstract

Nephrogenic diabetes insipidus (NDI; designated 304800 in Mendelian Inheritance in Man) is an X-linked disorder with abnormal renal and extrarenal V2 vasopressin receptor responses. The mutant gene has been mapped to Xq28 by analysis of RFLPs, and tight linkage between DXS52 and NDI has been reported. In 1969, Bode and Crawford proposed, under the term "the Hopewell hypothesis," that most cases in North America could be traced to descendants of Ulster Scots who arrived in Nova Scotia in 1761 on the ship Hopewell. They also suggested a link between this family and a large Mormon pedigree. DNA samples obtained from 13 independent affected families, including 42 members of the Hopewell and Mormon pedigrees, were analyzed with probes in the Xq28 region. Genealogical reconstructions were performed. Linkage between NDI and DXS304 (probe U6:2.spl), DXS305 (St35-691), DXS52 (St14-1), DXS15 (DX13), and F8C (F814) showed no recombination in 12 families, with a maximum lod score of 13.5 for DXS52. A recombinant between NDI and DXS304, DXS305, was identified in one family. The haplotype segregating with the disease in the Hopewell pedigree was not shared by other North American families. PCR analysis of the St14 VNTR allowed the distinction of two alleles that were not distinguishable by Southern analysis. Carrier status was predicted in 24 of 26 at-risk females. The Hopewell hypothesis cannot explain the origin of NDI in many of the North American families, since they have no apparent relationship with the Hopewell early settlers, either by haplotype or by genealogical analysis. We confirm the locus homogeneity of the disease by linkage analysis in ethnically diverse families. PCR analysis of the DXS52 VNTR in NDI families is very useful for carrier testing and presymptomatic diagnosis, which can prevent the first manifestations of dehydration.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1357965      PMCID: PMC1682824     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  30 in total

1.  Diabetes insipidus; clinical and experimental studies with consideration of genetic relationships.

Authors:  J F CANNON
Journal:  AMA Arch Intern Med       Date:  1955-08

2.  Rapid PCR analysis of the St14 (DXS52) VNTR.

Authors:  B Richards; R Heilig; I Oberlé; L Storjohann; G T Horn
Journal:  Nucleic Acids Res       Date:  1991-04-25       Impact factor: 16.971

Review 3.  Yeast artificial chromosome-based genome mapping: some lessons from Xq24-q28.

Authors:  D Schlessinger; R D Little; D Freije; F Abidi; I Zucchi; G Porta; G Pilia; R Nagaraja; S K Johnson; J Y Yoon; A Srivastava; J Kere; G Palmieri; A Ciccodicola; V Montanaro; G Romano; A Casamassimi; M D'Urso
Journal:  Genomics       Date:  1991-12       Impact factor: 5.736

4.  New informative polymorphism at the DXS304 locus, a close distal marker for the fragile X locus.

Authors:  F Rousseau; A Vincent; I Oberlé; J L Mandel
Journal:  Hum Genet       Date:  1990-02       Impact factor: 4.132

5.  Genetic mapping of new RFLPs at Xq27-q28.

Authors:  G K Suthers; I Oberlé; J Nancarrow; J C Mulley; V J Hyland; P J Wilson; J McCure; C P Morris; J J Hopwood; J L Mandel
Journal:  Genomics       Date:  1991-01       Impact factor: 5.736

6.  Physical map of human Xq27-qter: localizing the region of the fragile X mutation.

Authors:  A Poustka; A Dietrich; G Langenstein; D Toniolo; S T Warren; H Lehrach
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-01       Impact factor: 11.205

7.  Cloning and characterization of a vasopressin V2 receptor and possible link to nephrogenic diabetes insipidus.

Authors:  S J Lolait; A M O'Carroll; O W McBride; M Konig; A Morel; M J Brownstein
Journal:  Nature       Date:  1992-05-28       Impact factor: 49.962

8.  Molecular cloning of the receptor for human antidiuretic hormone.

Authors:  M Birnbaumer; A Seibold; S Gilbert; M Ishido; C Barberis; A Antaramian; P Brabet; W Rosenthal
Journal:  Nature       Date:  1992-05-28       Impact factor: 49.962

9.  Colocalization of the gene for nephrogenic diabetes insipidus (DIR) and the vasopressin type 2 receptor gene (AVPR2) in the Xq28 region.

Authors:  A M van den Ouweland; M T Knoop; V V Knoers; P W Markslag; M Rocchi; S T Warren; H H Ropers; F Fahrenholz; L A Monnens; B A van Oost
Journal:  Genomics       Date:  1992-08       Impact factor: 5.736

10.  Platelet vasopressin receptors in patients with congenital nephrogenic diabetes insipidus.

Authors:  D G Bichet; M F Arthus; M Lonergan
Journal:  Kidney Int       Date:  1991-04       Impact factor: 10.612

View more
  14 in total

1.  A case of nephrogenic diabetes insipidus with a novel missense mutation in the AVPR2 gene.

Authors:  Akira Ashida; Daisuke Yamamoto; Hyogo Nakakura; Hideki Matsumura; Shinichi Uchida; Sei Sasaki; Hiroshi Tamai
Journal:  Pediatr Nephrol       Date:  2007-01-10       Impact factor: 3.714

2.  X-linked nephrogenic diabetes insipidus mutations in North America and the Hopewell hypothesis.

Authors:  D G Bichet; M F Arthus; M Lonergan; G N Hendy; A J Paradis; T M Fujiwara; K Morgan; M C Gregory; W Rosenthal; A Didwania
Journal:  J Clin Invest       Date:  1993-09       Impact factor: 14.808

3.  Treatment of nephrogenic diabetes insipidus with hydrochlorothiazide and amiloride.

Authors:  V Kirchlechner; D Y Koller; R Seidl; F Waldhauser
Journal:  Arch Dis Child       Date:  1999-06       Impact factor: 3.791

4.  Nature and recurrence of AVPR2 mutations in X-linked nephrogenic diabetes insipidus.

Authors:  D G Bichet; M Birnbaumer; M Lonergan; M F Arthus; W Rosenthal; P Goodyer; H Nivet; S Benoit; P Giampietro; S Simonetti
Journal:  Am J Hum Genet       Date:  1994-08       Impact factor: 11.025

5.  Insertion of an Alu sequence in the Ca(2+)-sensing receptor gene in familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism.

Authors:  N Janicic; Z Pausova; D E Cole; G N Hendy
Journal:  Am J Hum Genet       Date:  1995-04       Impact factor: 11.025

6.  Functional polymorphisms affecting the clinically important arginine-137 residue of AVPR2 do not influence serum sodium concentration at the population level.

Authors:  Yi Fu; Tim Cheetham; David Bourn; Eric Orwoll; David M Cohen
Journal:  Physiol Genomics       Date:  2013-01-29       Impact factor: 3.107

7.  Nephrogenic diabetes insipidus: an X chromosome-linked dominant inheritance pattern with a vasopressin type 2 receptor gene that is structurally normal.

Authors:  E Friedman; A E Bale; E Carson; W L Boson; M Nordenskjöld; M Ritzén; P C Ferreira; A Jammal; L De Marco
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-30       Impact factor: 11.205

8.  Binding-, intracellular transport-, and biosynthesis-defective mutants of vasopressin type 2 receptor in patients with X-linked nephrogenic diabetes insipidus.

Authors:  H Tsukaguchi; H Matsubara; S Taketani; Y Mori; T Seido; M Inada
Journal:  J Clin Invest       Date:  1995-10       Impact factor: 14.808

Review 9.  Genetic kidney diseases.

Authors:  Friedhelm Hildebrandt
Journal:  Lancet       Date:  2010-04-10       Impact factor: 79.321

10.  Novel AVPR2 mutations and clinical characteristics in 28 Chinese families with congenital nephrogenic diabetes insipidus.

Authors:  Q Li; D Tian; J Cen; L Duan; W Xia
Journal:  J Endocrinol Invest       Date:  2021-06-08       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.